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emission computed tomography myocardial
perfusion imaging (SPECT-MPI) in a developing
community: A comparison between 2005 and
2009 versions of ACCF/ASNC appropriateness
criteria
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Introduction. Appropriateness of referrals for myocardial perfusion imaging (MPI) in
developing countries has not been extensively studied. Our study was conducted to describe the
ordering practices of physicians and appropriateness of MPI referrals in Iran.
Method. We prospectively applied 2005 and 2009 versions of the Appropriateness Use
Criteria published by the American College of Cardiology Foundation (ACCF) and the
American Society of Nuclear Cardiology (ASNC) to 291 consecutive patients (age
55.3 ± 10.3 years) who underwent SPECT-MPI. For this purpose, we convened a panel, con-
sisting of two academic cardiologists, one academic clinician in internal medicine, and one
academic clinician in nuclear medicine. The panelists were invited for a face-to-face meeting to
judge appropriateness of SPECT-MPI and independently assign a specific indication (scenario),
whenever possible, for each case in accordance with ACCF/ASNC appropriateness scenarios.
Results. Based on the 2005 ACCF/ASNC criteria, SPECT-MPI studies were judged
appropriate for 211 (72.5%), uncertain for 36 (12.4%), inappropriate for 32 (11.0%), and
unclassifiable for 12 (4.1%) referrals. The same figures based on the 2009 version were 219
(75.3%), 15 (5.2%), 49 (16.8%), and 8 (2.7%) patients, respectively. Overall agreement between
the 2005 and 2009 versions was good (j 0.63). Lack of chest pain and age below 60 years were
significant indicators increasing the likelihood of inappropriate referrals by 2.9-3.4 fold.
Absence of diabetes mellitus and hypertension, a normal lipid profile, lack of a past history of
myocardial infarction or cardiovascular interventions (CABGs or PCI), as well as lack of
application and exercise ECG stress test as the gate keeper (keeping abnormal ETT or inability
of the patient to perform exercise as the appropriate indication for SPECT-MPI referral) were
significant indicators, decreasing the odds of appropriate referrals. Generally a higher per-
centage of referrals with inappropriate indications had normal MPI.
Conclusion. Our study provides an evidence for the fact that SPECT-MPI ordering
practices in our developing community largely parallel the ACCF/ASNC recommendations.
The implementation of appropriateness criteria is feasible in clinical settings and might provide
an alternative to utilization management. (J Nucl Cardiol 2011;18:1044–52.)
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INTRODUCTION
Despite the relatively high cost, clinical imaging
modalities have shown rapid diffusion and increasing
application, even in low income countries.1,2 In fact,
documented evidence reveal that the number of clinical
imaging procedures and instruments have continued to
increase over the past decades.1-5 Accordingly, there has
been a movement for evidence justifying the cost of any
diagnostic or therapeutic procedure, ‘‘a movement of
evidence-based medicine which began as a result of
dramatic increases in the costs of health care that far
outpaced inflation and encumbered greater percentages
of the gross domestic product’’.6,7 In fact, dramatic
growth in the physicians’ request of imaging modalities
and their dependence on clinical imaging for diagnosis8
has led authorities to question the appropriateness of
referrals and to consider strategies to constrain further
diagnostic test growth. In this regard, special attention
has been paid to cardiovascular diagnostic procedures
due to their clinical importance and high costs.
Numerous studies are available that evaluate the con-
tributing factors in physicians’ decisions to refer a
patient for cardiac catheterization9-12 or cardiac com-
puted tomography.13
The number of single-photon emission computed
tomography myocardial perfusion imaging (SPECT-
MPI) performed annually has increased in many coun-
tries.5,14 For example, in Ontario (Canada) the number
has increased by 101% between 1996/1997 and
2005/2006.3 In Germany, the number of myocardial
perfusion scintigraphies increased between 2005 and
2006, despite the emergence of competing modalities.15
Until recently, the same trend was observed in other
European countries and the United States: since 1998,
the rates for SPECT-MPIs increased from 10% to 30%
per year.5,6 On the other hand, in recent years almost
80% of cardiovascular disease (CAD) deaths have
occurred in low- to middle-income countries.14 There-
fore, it is logically expected that application of SPECT-
MPI is also increasing in these nations.14,16 Such an
expectation was confirmed by Koh et al,17 who showed a
10% yearly growth in the application of SPECT-MPI in
Singapore since 1996.
Appropriateness of MPI referrals in developing
countries has not been studied extensively.18-20
Although emphasis has been made by authorities in the
American College of Cardiology Foundation (ACCF)
and the American Society of Nuclear Cardiology
(ASNC),21,22 it seems that little attention has thus far
been paid to this issue. This is mainly because health
technology assessment is not an organized scientific
effort in developing nations.1,23 On the other hand,
ethnic differences in the appropriateness of referrals
have been suggested. In a preliminary report from Sin-
gapore, Indians were more likely to have an
appropriately ordered and positive MPI than Chinese
and Malays.24 Accordingly, our study was conducted to
describe the ordering practices of physicians, and
appropriateness of MPI referrals, in multiple clinical
sites of a developing country (Iran), by use of the 2005
and 2009 versions of ACCF/ASNC criteria as the major
background reference.25,26
METHOD
All consecutive patients who underwent SPECT-MPI
from January to mid-February 2009 in four nuclear medicine
imaging centers (two private free-standing centers and two in
hospital governmental centers) were prospectively entered to
the study. After obtaining consent, all patients underwent
systematic history taking, physical examination and review of
the past medical records, to collect clinical data on the day of
their MPI appointment. For each patient, the following clin-
ical variables were recorded: patient age; sex; symptoms;
whether chest pain was typical, atypical, or non-anginal
(patients who had dyspnea rather than chest pain as a pre-
senting symptom were considered symptomatic with atypical
angina27); cardiovascular disease risk factors (including
smoking, hypertension, dyslipidemia, diabetes status, and
family history of CAD); history of previous CCU admissions;
resting ECG; the results of the exercise ECG test; and
results of other diagnostic tests (resting echocardiography,
stress echocardiography, previous SPECT-MPI scans, CT
angiography or interventional angiography) or invasive
revascularization (CABGs or PCI) undertaken prior to
SPECT-MPI referral. Only the most recent revascularization
procedures were considered if the patient had previously
undergone more than one therapeutic intervention.27 The
physician interviewer reported that data entry required at least
12 minute/patient.
Subsequently, as requested by the referring cardiologist,
and regardless of the results of the clinical variables reviewed
by the physician interviewer, SPECT-MPI was performed.
Two nuclear medicine physicians blinded to other clinical
characteristics interpreted the SPECT-MPI data. For study
purposes, each SPECT-MPI was interpreted as normal or
abnormal (including fixed defect(s), completely reversible
defect(s), or a partially reversible defect(s)).
Rating of Appropriateness
We convened a panel, consisting of two academic
cardiologists (AS and MR), one academic clinician in
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internal medicine (AA), and one academic clinician in
nuclear medicine (MM). The moderator, who was the phy-
sician responsible for collecting clinical data, history taking,
physical examination data and reviewing of past medical
records of the patients, and was unaware of the other pan-
elists’ ratings and SPECT-MPI results, presented each case
in the face-to-face panel meeting. Then the panelists were
invited to judge appropriateness of SPECT-MPI for each
patient on a 9-point scale (Rating 1), on which scores of 1-3
denoted inappropriate referral (no benefit of SPECT-MPI),
4-6 denoted uncertainty about use (when harms and benefits
were judged as approximately equal, or when the best
available evidence did not support a judgment either way),
and 7-9 denoted appropriate use (benefits were judged to
outweigh harms).28 Panel members had the opportunity to
modify their scores in light of the panel discussions, but no
effort was made to oblige the panelists for consensus. After
calculating the mean of scores from four panelists, a mean
score of 7-9 was considered appropriate (A), a score of
3.1-6.9 considered uncertain (U), and score of 1-3, inap-
propriate (I).
At the next step, panelists were asked to independently
assign a specific indication (scenario), whenever possible in
accordance with the 52 ACCF/ASNC appropriateness criteria
scenarios of version 2005, for each case (Rating 2). SPECT-
MPI studies were then classified into appropriate, inappropri-
ate, uncertain, or remained unclassified (i.e., when the
consensus of the panelists was that the case could not be
matched to any of the 52 presented scenarios of 2005 ACCF/
ASNC criteria). Similarly, Rating 3 was performed in accor-
dance with the 67 ACCF/ASNC appropriateness criteria
scenarios from the 2009 revision.26
The study was conducted with approval from the research
and ethical committee at the Golestan Cardiovascular Research
Center, Gorgan, Iran.
Statistical Analysis
Descriptive statistics, frequencies, and mean ± SD were
computed, as appropriate, for demographic and clinical char-
acteristics, presenting symptoms, previous diagnostic tests
performed, and results of SPECT-MPI. Agreement between
panelists beyond chance for Rating 1, based on the 3 defined
categories (i.e., inappropriate, uncertain, and appropriate) was
evaluated using the intra-class correlation (ICC) statistic and
values of 0.40-0.60 were considered as moderate agreement
and values greater than 0.60-0.80 were considered as good
agreement. Agreement between Ratings 2 and 3 beyond
chance was evaluated using kappa statistics.
Variations in the rate of appropriateness by baseline
demographic and clinical characteristics and SPECT-MPI
results were examined using chi-square and ANOVA for
categorical and continuous variables. Moreover, odds ratios
(OR) and their 95% confidence interval were calculated with
the appropriateness level as the dependent variable and
baseline demographic and clinical characteristics results as
independent variables. A P value of \.05 was considered
statistically significant. All statistical analyses were con-
ducted using SPSS version 13 (SPSS Inc., Chicago, IL,
USA).
Table 1. Baseline demographic and clinical
characteristics of the study population
Demographic and
clinical
characteristics Frequency (%)
Age (mean ± SD)
[C60 years]
55.3 ± 10.3 [95 (32.6%)]
Male gender 124 (42.6%)
Nuclear Medicine Center
Hospital-based
governmental
115 (39.5%)
Private free-standing 176 (60.5%)
Chest pain
Typical 54 (18.6%)
Atypical 111 (38.1%)
Non-anginal 59 (20.3%)
No chest pain 67 (23.0%)
Dyslipidemia 173 (59.7%)
Hypertension 146 (50.2%)
Diabetes mellitus 63 (21.6%)
Smoking 44 (15.1%)
Family history of CAD 19 (6.5%)
History of myocardial
infarction
33 (11.3%)
Previous CABGs or PCI 40 (13.7%)
Exercise ECG test
Unable to ETT 99 (34.0%)
Able to ETT 191 (65.6%)
Performed 86 (29.6%)
Abnormal 53 (18.2%)
Normal 32 (11.0%)
Missed data 1 (0.3%)
Not performed 105 (36.1%)
Missed data 1 (0.3%)
Resting echocardiogram
Performed 217 (74.6%)
Abnormal 102 (35.1%)
Normal 99 (34.0%)
Missed data 16 (5.5%)
Not performed 74 (25.4%)
There was no significant difference between hospital-based
governmental and private free-standing nuclear medicine
centers regarding the age (P .57), gender (P .053), chest pain
(0.67), dyslipidemia (P .37), hypertension (P .75), diabetes
mellitus (P .39), family history of CAD (P .46), history of
myocardial infarction (P .061), previous CABG or PCI (P .14),
exercise ECG test (P .29), and resting echocardiogram (P .37).
Smoking was significantly higher in patients of hospital-
based governmental centers as compared to private free-
standing nuclear medicine centers (21.7% vs 10.8%, P .01).
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RESULTS
Two hundred and ninety-one patients (167 female,
124 male) were entered into the study. The mean age of
the participants was 55.3 ± 10.3 years (range 24-
88 years). The demographic profile and baseline clinical
characteristics of the patients are shown in Table 1.
During the study period, the number of SPECT-MPI
studies performed in hospital-based governmental cen-
ters was significantly lower than the private free-standing
nuclear medicine centers (115 vs 176, P \ .001).
Appropriateness of Referrals
Based on the Rating 1, the level of appropriateness
of referrals for SPECT-MPI were judged appropriate for
163 of 291 (56.0%), uncertain for 97 of 291 (33.3%),
and inappropriate for 31 of 291 patients (10.7%).
Based on the 2005 ACCF/ASNC appropriateness
criteria (Rating 2), SPECT-MPI testing were judged
appropriate for 211 referrals (72.5%), uncertain for 36
(12.4%), and inappropriate for 32 (11.0%). The same
figures based on the 2009 version of ACCF/ASNC
appropriateness criteria (Rating 3) were 219 (75.3%), 15
(5.2%), and 49 (16.8%), respectively (Table 2). Panel-
ists had consensus that in 12 (4.1%) referrals, the cases
did not match to any of the 52 presented scenarios of the
2005 ACCF/ASNC criteria (unclassified). Out of these,
clinical interpretation of the panelists (Rating 1) was
appropriate, uncertain and inappropriate in 4, 6, and 2
patients, respectively. However, according to the 2009
version of the ACCF/ASNC criteria (Rating 3) the
number of unclassified cases was reduced to just eight
referrals (2.7%). Out of these, clinical interpretation of
the panelists (Rating 1) was appropriate, uncertain, and
inappropriate in 2, 6, and 0 patients, respectively.
Regarding the level of appropriateness of referrals,
there was no significant difference between hospital-
based governmental and private free-standing nuclear
medicine centers in Ratings 1, 2, and 3 (P values .44,
.25, and .22, respectively).
Indications for Referrals
Based on the Rating 2, just two clinical situations
accounted for more than 90% (29/32) of patients with
inappropriate referrals. These were evaluation of non-
acute ischemic equivalents in patients with low pre-test
probability of CAD and an interpretable ECG, and able
to exercise (No. 1), and the detection of CAD in low-
risk patients without chest pain syndrome (No. 10).
According to Rating 3, four clinical situations
accounted for almost 94% (46/49) of patients with
inappropriate referrals. These were evaluation of non-
acute ischemic equivalents in patients with low pre-test
probability of CAD and interpretable ECG and able to
exercise (No. 1), detection of CAD or risk assessment
in low or intermediate risk patients without ischemic
equivalents and an interpretable ECG (No. 12 and 13),
and patients with low-risk Duke Treadmill Score (No.
37).
According to Rating 3, those tests designated as
unclassifiable could be separated in three categories:
detection of CAD or risk assessment in intermediate risk
patients without ischemic equivalent and uninterpretable
ECG, but unable to perform exercise treadmill test (5
patients); valvular heart disease without chest pain
syndrome (2 patients); and, new-onset/diagnosed heart
failure with chest pain syndrome (1 patient).
According to Rating 2, those tests designated as
unclassifiable could be separated into these categories:
patients with a prior low (7 patients) and high (2
patients) risk Duke Treadmill Score; normal coronary
angiography in a patient with new symptoms; asymp-
tomatic patient at high risk for CAD; risk assessment
within 3 months of an acute coronary syndrome to
evaluate inducible ischemia.
Table 2. The agreement across the appropriateness levels between Rating 2 and 3
Rating 2 (2005)
Rating 3 (2009)
Appropriate Inappropriate Uncertain Unclassified Total
Appropriate 204 (70.1%) 0 (0.0%) 6 (2.1%) 1 (0.3%) 211 (72.5%)
Inappropriate 0 (0.0%) 32 (11.0%) 0 (0.0%) 0 (0.0%) 32 (11.0%)
Uncertain 11 (3.8%) 10 (3.4%) 8 (2.7%) 7 (2.4%) 36 (12.4%)
Unclassified 4 (1.4%) 7 (2.4%) 1 (0.3%) 0 (0.0%) 12 (4.1%)
Total 219 (75.3%) 49 (16.8%) 15 (5.2%) 8 (2.7%) 291 (100.0%)
j 0.63, P\ .001.
*P values are presented in detail in ‘‘Results’’ section
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Agreement
The overall agreement among the panelists across
the three appropriateness categories of Rating 1 was
good (ICC 0.68, P \ .001). The agreement across the
appropriateness levels between Rating 1, 2, and 3 was
also good (ICC 0.73, P \ .001). The overall agreement
between the 2005 and 2009 versions of the ACCF/
ASNC appropriateness criteria (Table 2) was good (j
0.63, P \ .001).
Risk Factors and Clinical Characteristics
The mean age of patients with inappropriate refer-
rals of Rating 3 was significantly lower than others
(49.9 ± 9.0 years vs 56.4 ± 10.2 years, P \ .001). Lack
of chest pain and age below 60 years were significant
indicators increasing the likelihood of inappropriate
referrals by 2.9-3.4 fold (Table 3). On the other hand,
lack of diabetes mellitus and hypertension, normal lipid
profile, lack of past history of myocardial infarction or
cardiovascular interventions (CABGs or PCI), as well as
lack of application of exercise ECG test as the gate
keeper test (keeping abnormal ETT or inability of the
patient to perform exercise as the appropriate indication
for SPECT-MPI referral), were significant indicators
which decreased the odds of appropriate referrals. Type
of imaging center (private or governmental), gender,
smoking, and family history of CAD as well as appli-
cation of resting echocardiography as the gate keeper
test (abnormal resting echocardiogram as the appropriate
indication for SPECT-MPI referral) did not affect
appropriateness of the referrals (Table 3).
Myocardial Perfusion Status
SPECT-MPIs were interpreted as normal in 203
(69.8%) and abnormal in 88 (30.2%) patients. Regarding
the myocardial perfusion status, no significant difference
existed between hospital-based governmental (ischemia
in 40 out 115 patients) and private free-standing nuclear
medicine centers (ischemia in 48 out 176 patients)
(P .17).
There was significant association between the level
of appropriateness and myocardial perfusion status in
both Rating 1 and 3 (P values of .003 and .006,
respectively), but in Rating 2 just a trend toward asso-
ciation was present (P .059). Generally a higher
percentage of referrals with inappropriate indications
were normal (Figure 1).
Table 3. Factors related to inappropriate referral
for SPECT-MPI, according to the 2009 version of
the ACCF/ASNC criteria (Rating 3)
Clinical
characteristic
and gate keeper
tests
Odds
ratio
95%
CI
P
value
Age\60 years 3.4 1.5–8.0 \.01
Female gender 1.7 0.9–3.2 .12
Private free-standing
centers
1.4 0.7–2.7 .28
No chest pain 2.9 1.5–5.5 \.01
Diabetes mellitus 0.2 0.1–0.7 \.01
Hypertension 0.4 0.2–0.8 \.01
Dyslipidemia 0.5 0.3–0.9 .02
Smoking 1.1 0.5–2.6 .79
Family history of CAD 0.9 0.3–3.3 .89
History of myocardial
infarction
0.8 0.8–0.9 \.01
Past history of CABGs
or PCI
0.8 0.8–0.9 \.01
Exercise ECG test as the
gate keeper test
(abnormal ETT or patient
unable to exercise)
0.2 0.1–0.4 \.001
Resting echocardiography
as the gate keeper test
(abnormal resting
echocardiogram)
1.3 0.7–2.5 .47
More or less, similar results were obtained using Rating 1 and
2, which are not presented here, in order to concise the
report.
Figure 1. Percentage of normal SPECT-MPI results based on
the level of appropriateness in different ratings. *P values are
presented in detail in ‘‘Results’’ section.
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DISCUSSION
Although our study population is considerably
younger (mean age of 55 years) than that reported from
prior studies,19,20,27 a fact that at first glance increases
the likelihood for inappropriate referrals, a high per-
centage of SPECT-MPI procedures in Iran are being
done with appropriate indications. In fact, using the
same criteria, our findings for appropriate requests for
SPECT-MPI is comparable to that found in
developed19,20,27 and other developing nations,24 where
64%-87% of studies were deemed appropriate. Non-
significant differences between these studies can be
explained partly by patient-related factors, given that
differences in patient characteristics and their overall
risk for CAD exist among different populations.19
Although the majority of referrals ([70%) in our
population were deemed appropriate, there are a sub-
stantive proportion of referrals that are judged to be
uncertain, inappropriate, or categorized as unclassified.
It is noteworthy that a remarkable percentage of the
inappropriate referrals ended in normal SPECT-MPIs
(Figure 1), a fact which is supported by other reports.24
Hence, regardless of the fact that in our community most
of the referrals are ordered with appropriate indications,
educational programs should be implemented to increase
knowledge and familiarity of cardiologists with the
current Appropriate Use Criteria and recommenda-
tions,26 in order to reduce the number of inappropriate
referrals, and subsequently total burden of health care
expenditures.
Our expertise and non-documented interviews with
cardiologists or non-cardiologists of our community
who order SPECT-MPI, even in academic environ-
ments, indicate that most of these physicians have
minimal awareness of the publication of appropriateness
criteria for the referral of diagnostic procedures, such as
ACCF/ASNC criteria. Although implementation of such
criteria into clinical practice is difficult to achieve, and
requires extensive education for cardiologists, educa-
tional interventions increase the adherence to the
criteria. Dissemination of the ACCF/ASNC criteria for
appropriate use of MPI26 as well as delivery of didactic
lectures and discussions about appropriate use criteria to
physicians who are authorized to order MPI studies have
been suggested to improve the ordering practices of
physicians.29 By emphasizing clinical indications for
SPECT-MPI testing based on published criteria, signif-
icant reductions in inappropriate referrals, especially of
low-risk patients, and an increase in appropriate refer-
rals, particularly for patients prior to non-cardiac
surgeries, have been demonstrated, although cost-
effectiveness and clinical implications of these changes
have not yet been investigated.29
The Effect of Clinical Judgment
Our study showed that the proportion of appropriate
referrals is considerably lower in Rating 1 as compared
to Rating 2 and 3. There are a very large number of
uncertain categorizations by the panel in Rating 1, which
is very problematic; this finding lends support in favor of
the published ACCF/ASNC criteria (Rating 2 and 3), as
both versions provide a more definitive categorization.
Several factors influence appropriateness of utili-
zation of SPECT-MPI. Unfortunately the ACC/ASNC
appropriateness criteria cannot take into account some
of the important baseline clinical descriptors that influ-
ence the decision to order SPECT-MPI, such as severity
and duration of patient’s complaints, as well as race,
ethnicity, and sex,30-34 factors which are taken into
account by a dynamic and flexible panel of experts (as
compared to inflexible criteria). For example, in the
judgment of our panelists, duration of 20 years of dia-
betes mellitus was different from the duration of just less
than 1 year,35 a fact which was not taken into consid-
eration by the current criteria. Other possible factors not
included in the current ACC-ASNC appropriateness
criteria are regional practice patterns, socioeconomic
factors, patients’ preference, availability of diagnostic
facilities, reimbursement, and insurance status, although
it can be assumed that they should not be considered in
any form of appropriateness criteria for any diagnostic/
risk assessment test. These limitations of guidelines can
be considered as an explanation of why inappropriate
referrals could never reach 0%.
Are Inappropriate Referrals Always
Inefficient?
Mehta et al27 have stated that some of the inap-
propriate referrals may have a clinically valuable impact
that alters long-term patients’ outcome. For example,
patients who are informed that they have an abnormal
SPECT-MPI, may be more apt to start and continue
lifestyle modifications including weight reduction and
smoking cessation, which may alter their long-term risk.
Also, based on our study findings, up to 12% of patients
with inappropriate referrals have SPECT-MPI abnor-
malities, which warrant further clinical work-up. Based
on this data, ‘‘NNI’’ (number needed to image) in the
inappropriate group to find a positive test is 8.3. This
observation shows that not all inappropriate referrals are
useless. On the other hand, as there are significant
concerns regarding the application of the ACCF/ASNC
criteria to prevent performance of, or deny reimburse-
ment, for those tests with ‘‘inappropriate’’ indication,
further outcomes data are required to carefully address
these indications.27 According to the introduction of
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both versions of ACCF/ASNC criteria, the inappropriate
rate is not anticipated to be 0%, as clinical judgment
must be considered, a fact which is supported by our
study findings. All health plans and regulatory bodies
are advised not to prevent testing for these indications,
but instead to track patterns and performance.
Unclassified Referrals
Based on the 2005 version of the ACCF/ASNC
criteria, 12 out of 291 patients (4.1%) were labeled as
unclassified since they were ordered for indications not
adequately addressed in the ACCF/ASNC criteria. This
figure was closely comparable to those (3%-7%) previ-
ously reported.19,27 However, the 2009 version of the
ACCF/ASNC criteria seems to be a little more com-
prehensive, as the number of unclassified cases was
reduced to just eight (2.7%). On the other hand, there
was no patient unclassified in both Rating 2 and 3. For
example, in our population we found a 62-year-old
female patient with moderate Framingham risk stratifi-
cation presented for myocardial perfusion imaging to
guide decision for invasive studies, which was clearly
classified as uncertain in the 2005 ACC/ASNC criteria.
No such corresponding scenario was listed in the 2009
ACC/ASNC criteria.
How to Improve Appropriateness
of Referrals?
Although the decisive role of clinician judgment in
the face of diverse medical presentations and varying
patient characteristics cannot be overlooked and con-
strained,27 appreciation of our study results will assist
clinicians to improve quality of patient care, and their
ordering practice in a cost-effective manner. Age of
younger than 60 years and lack of chest pain increases
the odds of inappropriate referrals 3.4 and 2.9 times,
respectively, and should be taken into account more
cautiously by the referring physician at the point of
ordering. On the contrary, concomitant cardiovascular
disease risk factors (including hypertension, dyslipide-
mia, and most importantly diabetes mellitus) and past
history of myocardial infarction and invasive revascu-
larizations are significant predictors that reduce the
number of inappropriate referrals (Table 3). Supporting
our study findings, Koh et al24 reported that a grading of
appropriate is significantly associated with patients who
are older or who had major cardiac risk factors,
including hypertension, dyslipidemia, or diabetes mel-
litus. Although previous reports stated that ‘‘the
inappropriate group of referrals is predominantly
composed of female patients’’,27 in our study this rela-
tionship was not significant.
The clinical importance of exercise ECG test as the
gatekeeper test to order SPECT-MPI procedures cannot
be overemphasized. Our study confirmed that the exer-
cise ECG test possesses the ability to determine which
patients should or should not undergo these costly, but
inherently cost-saving diagnostic tests. Bypassing exer-
cise ECG test—unless the patient is unable to perform
exercise due to physical disabilities or other clinical
limitations—leads to an increase in the number of
inappropriate referrals with the potential of rising costs
vs the benefits of the imaging modality.
LIMITATIONS
Although no effort was made to reach consensus
after panel discussion, this may limit the true individual
scoring and introduce some form of harmonization and
will impact the calculated measures of agreement.
The main drawback of our study was the sample
size studied. Larger sample sizes have been studied
using an automated system.19 However, we believe that
such a computerized software analysis is not as reliable
as a panel of experts in this field who make judgments
after reviewing all clinical data, and more precisely
report their decision.
Also regarding the fact that in our study angio-
graphic and follow-up outcomes data were not
prospectively sought, it was impossible to correlate
perfusion abnormalities with angiographic abnormalities
and prognosis. Nevertheless, the accuracy of SPECT-
MPI to reveal angiographic stenosis is well described,
and the potential of SPECT-MPI to predict prognosis is
also well established and has been reported to exceed
that of angiography.28
CONCLUSION
Our study provides evidence that SPECT-MPI
ordering practices in a developing country largely
parallel the ACCF/ASNC recommendations. The
implementation of appropriateness criteria is feasible in
clinical settings and might provide an alternative to
utilization management.
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